Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

FGF (Fibroblast Growth Factor)

  • Masaru Katoh
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_313

Synonyms

 Acidic FGF;  aFGF;  Basic FGF;  bFGF;  FGF;  FGF1;  FGF10;  FGF11;  FGF12;  FGF13;  FGF14;  FGF16;  FGF17;  FGF18;  FGF19;  FGF2;  FGF20;  FGF-20;  FGF21;  FGF22;  FGF23;  FGF3;  FGF4;  FGF5;  FGF6;  FGF7;  FGF8;  FGF9;  int-2;  K-FGF;  KGF

Historical Background

The founding members of the fibroblast growth factor (FGF) family are FGF1 (acidic FGF or aFGF) and FGF2 (basic FGF or bFGF), which were initially purified from bovine brain and pituitary gland as mitogens for fibroblasts. Mouse Fgf3 (int-2) was cloned and characterized as a proto-oncogene that is aberrantly upregulated in mammary tumors due to the proviral integration of mouse mammary tumor virus (MMTV). Human FGF4 (K-FGF) was cloned and characterized as a proto-oncogene following the transfection of genomic DNA from Kaposi sarcoma into mouse NIH 3T3 cells. In addition, 18 FGFs have been cloned and characterized based on their homology to FGF1 ~ FGF4 (Reviewed in Katoh 2002). Because the CCND1 – ORAOV1 – FGF19 – FGF4...

This is a preview of subscription content, log in to check access.

References

  1. ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26:345–8.CrossRefGoogle Scholar
  2. Barak H, Huh SH, Chen S, Jeanpierre C, Martinovic J, Parisot M, et al. FGF9 and FGF20 maintain the stemness of nephron progenitors in mice and man. Dev Cell. 2012;22:1191–207.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Carpenter TO, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Wooddell MM, et al. Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. J Clin Invest. 2014;124:1587–97.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Carter EP, Fearon AE, Grose RP. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction. Trends Cell Biol. 2015;25:221–33.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Dalski A, Atici J, Kreuz FR, Hellenbroich Y, Schwinger E, Zühlke C. Mutation analysis in the fibroblast growth factor 14 gene: frameshift mutation and polymorphisms in patients with inherited ataxias. Eur J Hum Genet. 2005;13:118–20.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Degirolamo C, Sabba C, Moschetta A. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Nat Rev Drug Discov. 2016;15:51–69.PubMedPubMedCentralCrossRefGoogle Scholar
  7. El Agha E, Kosanovic D, Schermuly RT, Bellusci S. Role of fibroblast growth factors in organ regeneration and repair. Semin Cell Dev Biol. 2016;53:76–84.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Folsom LJ, Imel EA. Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action. Curr Osteoporos Rep. 2015;13:78–87.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Higgins CA, Petukhova L, Harel S, Ho YY, Drill E, Shapiro L, et al. FGF5 is a crucial regulator of hair length in humans. Proc Natl Acad Sci USA. 2014;111:10648–53.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Jamsheer A, Zemojtel T, Kolanczyk M, Stricker S, Hecht J, Krawitz P, et al. Whole exome sequencing identifies FGF16 nonsense mutations as the cause of X-linked recessive metacarpal 4/5 fusion. J Med Genet. 2013;50:579–84.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Katoh M. WNT and FGF gene clusters. Int J Oncol. 2002;21:1269–73.PubMedPubMedCentralGoogle Scholar
  12. Katoh M. WNT signaling in stem cell biology and regenerative medicine. Curr Drug Targets. 2008;9:565–70.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Katoh M. Therapeutics targeting FGF signaling network in human diseases. Prends Pharmacol Sci. 2016;37:1081–96.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Katoh M, Katoh M. Evolutionary conservation of CCND1 – ORAOV1 – FGF19 – FGF4 locus from zebrafish to human. Int J Mol Med. 2003;12:45–50.PubMedPubMedCentralGoogle Scholar
  15. Katoh M, Nakagama H. FGF receptors: cancer biology and therapeutics. Med Res Rev. 2014;34:280–300.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Kirikoshi H, Sagara N, Saitoh T, Sekihara H, Shiokawa K, Katoh M. Molecular cloning and characterization of human FGF-20 on chromosome 8p21.3-p22. Biochem Biophys Res Commun. 2000;274:337–43.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Milunsky JM, Zhao G, Maher TA, Colby R, Everman DB. LADD syndrome is caused by FGF10 mutations. Clin Genet. 2006;69:349–54.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Miraoui H, Dwyer AA, Sykiotis GP, Plummer L, Chung W, Feng B, et al. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet. 2013;92:725–43.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Ornitz DM, Itoh N. The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol. 2015;4:215–66. .xPubMedPubMedCentralCrossRefGoogle Scholar
  20. Tekin M, Oztürkmen Akay H, Fitoz S, Birnbaum S, Cengiz FB, et al. Homozygous FGF3 mutations result in congenital deafness with inner ear agenesis, microtia, and microdontia. Clin Genet. 2008;73:554–65.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Tian H, Zhao Y, Chen N, Wu M, Gong W, Zheng J, et al. High production in E. coli of biologically active recombinant human fibroblast growth factor 20 and its neuroprotective effects. Appl Microbiol Biotechnol. 2016;100:3023–34.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Trarbach EB, Abreu AP, Silveira LF, Garmes HM, Baptista MT, Teles MG, et al. Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency. J Clin Endocrinol Metab. 2010;95:3491–6.PubMedPubMedCentralCrossRefGoogle Scholar
  23. Wang G, van der Walt JM, Mayhew G, Li YJ, Züchner S, Scott WK, et al. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of a-synuclein. Am J Hum Genet. 2008;82:283–9.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Zhang J, Li Y. Therapeutic uses of FGFs. Semin Cell Dev Biol. 2016;53:144–54.PubMedPubMedCentralCrossRefGoogle Scholar
  25. Zhao X, Wu Y, Zhao C, Feng M. Association between FGF20 rs12720208 gene polymorphism and Parkinson’s disease: a meta-analysis. Neurol Sci. 2016;37:1119–26.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Zhu R, Zhu Y, Liu X, He Z. Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson’s disease: a meta-analysis. Neurol Sci. 2014;35:1889–94.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Omics NetworkNational Cancer CenterTokyoJapan